Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab.

Makri, Olga E; Tsapardoni, Foteini N; Plotas, Panagiotis; Pallikari, Athina; Georgakopoulos, Constantine D

Makri, Olga E; Tsapardoni, Foteini N; Plotas, Panagiotis; Pallikari, Athina; Georgakopoulos, Constantine D.

Afiliación

Makri OE; Department of Ophthalmology, University of Patras, Patras, Greece, cgeorg@upatras.gr.
Tsapardoni FN; Department of Ophthalmology, University of Patras, Patras, Greece, cgeorg@upatras.gr.
Plotas P; Department of Ophthalmology, University of Patras, Patras, Greece, cgeorg@upatras.gr.
Pallikari A; Department of Ophthalmology, University of Patras, Patras, Greece, cgeorg@upatras.gr.
Georgakopoulos CD; Department of Ophthalmology, University of Patras, Patras, Greece, cgeorg@upatras.gr.

Int Med Case Rep J ; 11: 229-231, 2018.

Article en En | MEDLINE | ID: mdl-30271222

Palabras clave

aflibercept; angioid streaks; choroidal neovascularization; intravitreal; ranibizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Int Med Case Rep J Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google